Regulatory Phase I Clinical Trials

SGS is one of the world’s leading early clinical development contract research organizations.

Our clinical Phase I Unit provides clients with a full range of clinical research services compliant with EMEA and FDA requirements to facilitate your “go/no go” decisions during clinical development. We offer a large range of Phase I studies including drug interaction (DDI), TQT/QTc, as well as BA/BE and ADME/pharmacokinetic studies.

TQT/QTc trials

SGS performs five to six TQT/QTc studies per year with an average of 24,000 ECGs per trial. We offer:

• Compliance with the latest regulatory guidelines (FDA, ICH), 21 CFR part 11 compliance
• Unmatched reading accuracy and low variability (intraSD < 1 ms, interSD < 2 ms) allowing reduction of sample size
• 100% digital workflow

With partners specializing in cardiac data reading (ECG/Holter), we have developed a strong expertise in providing high-quality ECG reading and analysis in QT prolongation and safety pharmacology studies to the pharmaceutical and biotech industries.

Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), ADME/Pharmacokinetic Services:

• Drug-drug interaction studies including assay of the interacting drug (many validated methods available)
• Pharmacokinetic studies in special populations, including:
  • Elderly
  • Race
  • Gender
  • Renal impairment, including dialysis
  • Liver impairment
• Absorption, distribution, metabolism and excretion (ADME) –C14 labeled trials, including full GMP manufacturing of the medications
• Clinical pharmacokinetics and pharmacodynamics
• Bioavailability and bioequivalence studies including transdermal systems

Contact SGS today to learn how we can help with your early Phase I clinical trials.

Exploratory DevelopmentExploratory Development to Proof of Concept Integrated services reduce time to market (PDF 876KB) ...

Metabolic SyndromeMetabolic Syndrome: Trial Design Key PointsConducting a clinical trial in Metabolic Syndrome (PDF 98KB) ...

• Conducting QT Trials

  Alternative routes for a TQT trial – Part 1
  Conducting QT Trials
• Conducting QT Trials

  Alternative routes for a TQT trial – Part 2
  Conducting QT Trials
• Combined Protocols

  Saving time & money in early clinical development
  Combined Protocols Webinar

Interactive Pocket MapLife Science Services & Sites Pocket MapA quick reference to our global sites and services

Now Viewing

All 6 resources

• 

  Exploratory Development

  published 02/28/12

  PDF

• 

  Metabolic Syndrome

  published 02/29/12

  PDF

• 

  Conducting QT Trials

  published 02/28/12

  Video

• 

  Conducting QT Trials

  published 02/28/12

  Video

• 

  Combined Protocols Webinar

  published 02/28/12

  Video

• 

  Interactive Pocket Map

  published 06/06/12

  Video